메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

WELLFITXPLORE 2025 CONCLUDES WITH GREAT SUCCESS: ADVANCING THE "HEALTHY MACAO BLUEPRINT" AND BUILDING A BENCHMARK PLATFORM FOR HEALTH AND WELLNESS IN THE ASIA-PACIFIC

MACAO, Nov. 24, 2025 -- From November 22 to 23, WellFitXplore 2025—the Asia-Pacific Health & Wellness Training Festival—was successfully held at MGM COTAI in Macao. Organized by CrossFit China and proudly sponsored by MGM, this regional flagship event embraced the theme "EMPOWER HEALTH • ENHANCE WELLNESS," leveraging an integrated model of Competition + Education + Industry. The event carried forward the momentum from the 15th National Games, aligned with Macao's "Healthy Macao Blueprint," and injected sustainable health-driven vitality into Macao's diversified economi
- 노기식 기자
- 2025-11-25 08:16
August Global Partners Closes Flagship Healthcare Fund Above Target, Expanding AUM to $350 Million

SINGAPORE, Nov. 25, 2025 -- August Global Partners ("AGP"), Asia's leading independent healthcare and technology investor, today announced the successful close of its second fund, the AGP Healthcare Fund ("AGPHC") of $150 million, surpassing initial fundraising targets despite persistent headwinds in the global private equity and venture capital landscape. AGP's founding partners – who played a formative role in shaping Singapore's biomedical sector and championed Singapore EDBI's global investment efforts across healthcare, technology and deeptech – have attracted
- 황정호 기자
- 2025-11-25 08:00
Fisher Investments、「働きがいのある会社（Great Place to Work®）」に認定

Fisher Investmentsは職場文化に関する意識調査を実施する国際的調査機関による認定を受けました日本東京都, 2025年11月25日 -- Fisher Investments Japanおよび米国を拠点とする親会社のFisher Investmentsはこのたび、職場文化と職場での体験に関する意識調査を実施する国際的独立調査機関から「働きがいのある会社（Great Place to Work®）」として認定を受けました。「働きがいのある会社」認定は、対象企業の報酬、福利厚生、キャリアアップの機会、経営陣の経営能力、職場の全体的な雰囲気といった主要項目について調査した匿名の従業員アンケートの結果をもとに実施されます。Fisher Investments Japanの社員からのアンケートの回答によると、「公平」で「歓迎されている」と感じられる「サービス重視」の職場環境であるという評価を得ています。最高経営責任者（CEO）：ダミアン・オルナーニは「弊社の「働きがいのある会社」認定について、実に光栄なことであります」と述べ、「本認定は、社員が評価されていると感じ、成功できるというモチベーションと自信がもてる文化の育成に専念する弊社の姿勢によるものだと考えます。社員とその成長に力を注ぎ込む
- 황정호 기자
- 2025-11-25 06:00
UNIDO Announces Winners of Inaugural One World Sustainability Awards in Riyadh

RIYADH, Saudi Arabia, Nov. 25, 2025 -- UNIDO has announced the winners of the inaugural ONE World Sustainability Awards at the twenty-first session of the UNIDO General Conference (GC21) in Riyadh, Saudi Arabia, celebrating innovators whose work advances sustainable, inclusive industrial development across the globe. H.E. Vice Minister of Industry and Mineral Resources for Industrial Affairs of Saudi Arabia, Eng. Khalil bin Ibrahim bin Salamah, emphasized the transformative power of the awards: "These awards send a clear message to the world. They show that profitability a
- 황정호 기자
- 2025-11-25 05:05
FROM MEDICAL SUPPLIER TO MULTI-INDUSTRY LEADER: LIVINGSTONE INTERNATIONAL'S UNIQUE GROWTH STRATEGY

SYDNEY, Nov. 25, 2025 -- One of Australia's largest medical supply companies is celebrating its unique warehousing and supply chain strategy that has seen it grow into a leading manufacturer, importer, and supplier to more than 20 key industries. Livingstone International supplies more than 65,000 essential health, hygiene, education, beauty, and hospitality products to industries including aged care, schools and universities, hair and skin clinics, pharmacy, dental, mining, and government. Livingstone International Managing Director, Daniel Linn, said the company has no
- 김갑성 기자
- 2025-11-25 05:00
Fisher Investments Recognised as a Great Place to Work®

Fisher Investments was certified by global authority on workplace culture SYDNEY, Nov. 25, 2025 -- Fisher Investments Australia and its US-based parent company, Fisher Investments, were certified by Great Place to Work®, an independent, global authority on workplace culture and employee experience. Great Place to Work® certifies companies based on anonymous employee survey results across key factors including compensation, benefits, career advancement opportunities, competence of management and overall workplace atmosphere. Survey feedback revealed Fisher Investm
- 황정호 기자
- 2025-11-25 04:00
SOLO LEVELING: ARISE OVERDRIVE LAUNCHES TODAY ON STEAM AND XBOX PC

[ 메디채널 김장윤(JASON KIM) 기자 ] Launch Trailer Drops, Featuring Sung Jinwoo's Ascension to Become the Ultimate Monarch of Shadows SEOUL, South Korea, Nov. 25, 2025 -- Solo Leveling: ARISE OVERDRIVE, developed by Netmarble Neo and published by Netmarble, is available now on Steam and Xbox PC, with a new trailer to celebrate its official release. Based on the worldwide megahit webtoon Solo Leveling, this action RPG delivers an original take on a beloved adventure that fans have been waiting for. Complete with gorgeously animated combat, deep progression systems, and dynamic b
- 김장윤(JASON KIM) 기자
- 2025-11-25 03:00
HKeyBio Launches the HKEY-AIDMD 3.0--a Next-Generation Platform to Crack the Toughest Challenge in Autoimmune and Allergy Drug Development: Multi-target Combination Strategy Optimization

[ 메디채널 김갑성 기자 ] The newly upgraded HKEY-AIDMD 3.0 model library features nearly 300 autoimmune and allergy-related disease models. For multiple major indications, HKeyBio has established four-dimensional (4D) model pools that simulate clinical heterogeneity, providing a mechanism-driven model selection platform for evaluating multi-target combination therapies. The HKEY-AIDMD 3.0 omics database integrates spatiotemporal single-cell and spatial omics across various tissues and immune systems from the model library. This significantly improves resolution in identifying the differentiating ad
- 김갑성 기자
- 2025-11-25 00:30
Menarini Group Announces New Data on ELZONRIS® (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN) BPDCN is a highly aggressive, orphan hematologic malignancy that primarily affects skin, bone marrow, and blood FLORENCE, Italy and NEW YORK, Nov. 24, 2025 -- The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology
- 김갑성 기자
- 2025-11-24 23:34
Alzheimer's Association Statement on Oral Semaglutide Phase 3 Topline Data Release

- Results Underscore Need for Continued Research and Diverse Treatment Pipeline CHICAGO, Nov. 24, 2025 -- The Alzheimer's Association is disappointed that the evoke and evoke+ clinical trials did not demonstrate a statistically significant reduction in Alzheimer's disease progression. The studies tested an oral semaglutide pill for the treatment of early-stage symptomatic Alzheimer's disease. "While these results are not what we had hoped for, they will contribute to our understanding of this devastating and fatal disease," said Joanne Pike, DrPH, Alzheimer's A
- 김갑성 기자
- 2025-11-24 23:19

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-11-29_SAT

2025-11-28_FRI

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 29일 10시 40분